Aspen Aerogels, Inc. (ASPN) - What Are Analysts Thinking About This Stock?

Key Points

• Analysts have a mixed view: Seven brokerages give Aspen Aerogels an average “Hold” rating, with four buys, one hold and two sells. The average 12-month price target is $5.94.
• Aspen Aerogels reported a quarterly loss of $0.22 per share, slightly better than estimates, while revenue of $49.85 million exceeded forecasts. Analysts expect a full-year loss of $0.69 per share.
• Insider selling contrasts with strong institutional ownership: Major shareholder Wood River Capital sold 12.28 million shares for about $58.1 million, while hedge funds and other institutions own 97.64% of the company.

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) has received an average recommendation of "Hold" from the seven brokerages that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, one has given a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $5.94.

ASPN has been the subject of several recent research reports. Weiss Ratings reiterated a "sell (d-)" rating on shares of Aspen Aerogels in a report on Monday, September 21st. B. Riley Financial restated a "buy" rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Roth Capital reaffirmed a "buy" rating and set a $7.75 price objective on shares of Aspen Aerogels in a report on Friday, August 7th. Wall Street Zen raised shares of Aspen Aerogels from a "sell" rating to a "hold" rating in a report on Saturday. Finally, Barclays increased their target price on shares of Aspen Aerogels from $4.00 to $5.00 and gave the company an "underweight" rating in a report on Tuesday, August 11th.

Aspen Aerogels Price Performance

Shares of NYSE:ASPN opened at $5.06 on Friday. The company has a quick ratio of 2.24, a current ratio of 2.52 and a debt-to-equity ratio of 0.36. Aspen Aerogels has a twelve month low of $2.30 and a twelve month high of $8.56. The stock's 50 day moving average is $5.25 and its 200-day moving average is $4.67. The firm has a market capitalization of $419.93 million, a price-to-earnings ratio of -3.31 and a beta of 3.06.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. The firm had revenue of $49.85 million for the quarter, compared to analyst estimates of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. Sell-side analysts forecast that Aspen Aerogels will post -0.69 EPS for the current fiscal year.

Insider Activity at Aspen Aerogels

In related news, major shareholder Wood River Capital, Llc sold 12,280,426 shares of Aspen Aerogels stock in a transaction on Wednesday, September 23rd. The stock was sold at an average price of $4.73, for a total transaction of $58,086,414.98. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.96% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Aspen Aerogels

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. bought a new position in shares of Aspen Aerogels during the 2nd quarter worth $33,457,000. Oaktop Capital Management II L.P. purchased a new stake in Aspen Aerogels in the 2nd quarter worth about $32,769,000. George Kaiser Family Foundation bought a new stake in Aspen Aerogels in the 2nd quarter valued at about $20,081,000. Rice Hall James & Associates LLC bought a new stake in Aspen Aerogels in the 2nd quarter valued at about $10,368,000. Finally, Deutsche Bank AG purchased a new stake in Aspen Aerogels during the second quarter valued at about $2,359,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc is an advanced materials company that develops, manufactures and sells aerogel-based products. Aerogels are highly porous materials used for thermal management, insulation and protection. The company serves customers in the energy, industrial, transportation and building materials markets.

Its product portfolio includes thermal barriers designed to help protect electric vehicle batteries from thermal runaway, as well as insulation products for industrial, energy infrastructure and building applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.